The above cellular changes in advanced PCa cells, as well as intratumoral androgen biosynthesis, could render the tumors resistant to conventional AR-targeted therapies, including surgical or chemical castration and androgen antagonists (22, –, 27). Here, AR is linked to posterior cortical atrophy.